sellModerate cluster of 3
Miljkovic Milos sold $908k of RNAC
Chief Medical Officer at Cartesian Therapeutics, Inc.. 55,000 shares at an average of $16.50, traded Nov 14, 2024, filed Nov 18, 2024.
Warning score
59Value
$908k
55,000 shares
Holdings after
18,273
-103% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001453687-24-000130, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | MOption exercise Common Stock | +35,000 | $3.23 | $113k | 53,273 | Nov 18, 2024 |
| Nov 14, 2024 | SOpen-market sale Common Stock | -35,000 | $16.13 | $565k | 18,273 | Nov 18, 2024 |
| Nov 15, 2024 | MOption exercise Common Stock | +20,000 | $3.23 | $65k | 38,273 | Nov 18, 2024 |
| Nov 15, 2024 | SOpen-market sale Common Stock | -20,000 | $17.14 | $343k | 18,273 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | - | - | 50,528 | Nov 18, 2024 |
| Nov 15, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -20,000 | - | - | 30,528 | Nov 18, 2024 |
Related signals
Other insiders at Cartesian Therapeutics, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 40Moderate | buy | RNAC Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A director, owner | $965k | 52,189 | |
| 20Weak | sell | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $345k | 13,664 | |
| 55Moderate | sell 3 | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $649k | 38,689 | |
| 58Moderate | sell 3 | RNAC Cartesian Therapeutics, Inc. | Jewell Christopher M Chief Scientific Officer | $875k | 52,115 | |
| 60Notable | sell 3 | RNAC Cartesian Therapeutics, Inc. | Kurtoglu Metin Chief Technology Officer | $1.4M | 82,368 | |
| 43Moderate | buy | RNAC Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A director, owner | $7.4M | 431,940 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.